CSIMarket
 


Teleflex Incorporated  (TFX)
Other Ticker:  
 

Teleflex Incorporated's Leverage Ratio

TFX's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to repayements of liabilities of -3.59% Teleflex Incorporated improved Leverage Ratio in second quarter 2024 to 0.51, a new company low.

Within Medical Equipment & Supplies industry in the second quarter 2024, 53 other companies have achieved lower Leverage Ratio than Teleflex Incorporated in the II Quarter 2024. While Leverage Ratio total ranking has improved so far in the second quarter 2024 to 654, from total ranking in the first quarter 2024 at 784 .

Explain Leverage Ratio?
Who are TFX Customers?
What are TFX´s Total Liabilities?


TFX Leverage Ratio (Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Oct 01 2023)
III. Quarter
(Jul 02 2023)
II. Quarter
Y / Y Equity Change 8.15 % 9.56 % 10.42 % 10.75 % 9.41 %
Y / Y Total Liabilities Change 6.6 % 4.79 % 5.32 % 12.74 % -8.82 %
Leverage Ratio MRQ 0.51 0.54 0.57 0.62 0.52
TFX's Total Ranking # 654 # 784 # 472 # 363 # 658
Seq. Equity Change 1.23 % 1.4 % 2.94 % 2.35 % 2.55 %
Seq. Total Liabilities Change -3.59 % -4.37 % -5.77 % 22.69 % -5.22 %



Leverage Ratio second quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 54
Healthcare Sector # 237
Overall Market # 654


Leverage Ratio Statistics
High Average Low
1.54 0.97 0.51
(Dec 31 2017)   (Jun 30 2024)




Financial Statements
Teleflex Incorporated's Equity $ 4,559 Millions Visit TFX's Balance sheet
Teleflex Incorporated's Total Liabilities $ 2,327 Millions Visit TFX's Balance sheet
Source of TFX's Sales Visit TFX's Sales by Geography


Cumulative Teleflex Incorporated's Leverage Ratio

TFX's Leverage Ratio for the trailling 12 Months

TFX Leverage Ratio

(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Oct 01 2023)
III. Quarter
(Jul 02 2023)
II. Quarter
Y / Y Equity TTM Growth 8.15 % 9.56 % 10.42 % 10.75 % 9.41 %
Y / Y Total Liabilities TTM Growth 6.6 % 4.79 % 5.32 % 12.74 % -8.82 %
Leverage Ratio TTM 0.56 0.56 0.57 0.57 0.57
Total Ranking TTM # 47 # 4 # 847 # 6 # 1
Seq. Equity TTM Growth 1.23 % 1.4 % 2.94 % 2.35 % 2.55 %
Seq. Total Liabilities TTM Growth -3.59 % -4.37 % -5.77 % 22.69 % -5.22 %


On the trailing twelve months basis Due to repayements of liabilities of -3.59% Teleflex Incorporated has not changed Leverage Ratio in the 12 months ending in II Quarter 2024 to 0.56, above the Teleflex Incorporated's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry 2, during the past 12 months, other companies have achieved lower Leverage Ratio than Teleflex Incorporated. While Leverage Ratio total ranking has deteriorated during the twelve months ending in the II Quarter 2024, compared to the prior period, from 4 to 47.

Explain Leverage Ratio?
Who are TFX Customers?
What are TFX´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 3
Healthcare Sector # 11
Within the Market # 47


trailing twelve months Leverage Ratio Statistics
High Average Low
0.91 0.45 0.04
(Jul 01 2018)   (Dec 31 2017)




Companies with similar Leverage Ratio in the quarter ending Jun 30 2024, within Medical Equipment & Supplies Industry Leverage RatioJun 30 2024 MRQ Total LiabilitiesJun 30 2024 MRQ Equity
Nuo Therapeutics Inc   1.37 $ 0.822  Millions$ 0.599  Millions
Henry Schein Inc   1.36 $ 5,652.000  Millions$ 4,148.000  Millions
Dentsply Sirona Inc   1.25 $ 3,833.000  Millions$ 3,064.000  Millions
Avinger Inc   1.23 $ 9.542  Millions$ 7.753  Millions
Msa Safety Inc  1.17 $ 1,209.924  Millions$ 1,033.647  Millions
  1.13 $ 19.209  Millions$ 16.983  Millions
Masimo Corp  1.11 $ 1,525.100  Millions$ 1,368.800  Millions
Paragon 28 inc   1.11 $ 163.401  Millions$ 146.835  Millions
Reshape Lifesciences Inc   1.11 $ 3.358  Millions$ 3.035  Millions
Encision Inc   1.05 $ 1.960  Millions$ 1.860  Millions
U S Physical Therapy Inc  1.03 $ 502.276  Millions$ 485.615  Millions
Icu Medical Inc  1.03 $ 2,099.758  Millions$ 2,037.812  Millions
Infusystem Holdings Inc  1.03 $ 55.040  Millions$ 53.487  Millions
Bausch and Lomb Corp  1.03 $ 6,746.000  Millions$ 6,580.000  Millions
Vivani Medical Inc   1.02 $ 24.400  Millions$ 23.824  Millions
Integer Holdings Corporation  1.01 $ 1,563.773  Millions$ 1,553.910  Millions
Genedx Holdings Corp   1.01 $ 195.057  Millions$ 194.043  Millions
Vaso Corporation  1.00 $ 26.837  Millions$ 26.721  Millions
Carlisle Companies Incorporated  0.98 $ 2,949.800  Millions$ 3,004.300  Millions
Livanova Plc  0.97 $ 1,210.646  Millions$ 1,242.542  Millions
Innovage Holding Corp  0.97 $ 270.053  Millions$ 277.608  Millions
National Vision Holdings Inc   0.96 $ 807.088  Millions$ 843.408  Millions
Medtronic Plc  0.86 $ 41,306.000  Millions$ 48,160.000  Millions
Merit Medical Systems Inc  0.84 $ 1,077.651  Millions$ 1,282.445  Millions
Catheter Precision Inc   0.83 $ 11.944  Millions$ 14.317  Millions
Dariohealth Corp   0.78 $ 52.910  Millions$ 68.055  Millions
Axogen inc   0.74 $ 71.263  Millions$ 95.687  Millions
Silk Road Medical Inc   0.74 $ 115.123  Millions$ 154.684  Millions
Envista Holdings Corporation  0.74 $ 2,210.100  Millions$ 2,976.700  Millions
Privia Health Group Inc   0.74 $ 475.456  Millions$ 643.607  Millions

Date modified: 2024-09-13T04:08:43+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com